Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 519

    1.

    Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy.

    Yasuda G, Ando D, Hirawa N, Umemura S, Tochikubo O.

    Diabetes Care. 2005 Aug;28(8):1862-8.PMID: 16043724 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.

    Yasuda G, Hasegawa K, Kuji T, Ogawa N, Shimura G, Umemura S, Tochikubo O.

    Diabet Med. 2005 Oct;22(10):1394-400.PMID: 16176202 [PubMed - indexed for MEDLINE]Related articles

    3.

    Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction.

    Houlihan CA, Akdeniz A, Tsalamandris C, Cooper ME, Jerums G, Gilbert RE.

    Diabetes Care. 2002 Jun;25(6):1072-7.PMID: 12032117 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.

    Andersen S, Jacobsen P, Tarnow L, Rossing P, Juhl TR, Parving HH.

    Nephrol Dial Transplant. 2003 Feb;18(2):293-7.PMID: 12543883 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy.

    Holdaas H, Hartmann A, Berg KJ, Lund K, Fauchald P.

    Nephrol Dial Transplant. 1998 Dec;13(12):3096-102.PMID: 9870472 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A low-sodium diet potentiates the effects of losartan in type 2 diabetes.

    Houlihan CA, Allen TJ, Baxter AL, Panangiotopoulos S, Casley DJ, Cooper ME, Jerums G.

    Diabetes Care. 2002 Apr;25(4):663-71.PMID: 11919122 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria.

    Esmatjes E, Flores L, Iñigo P, Lario S, Ruilope LM, Campistol JM.

    Nephrol Dial Transplant. 2001;16 Suppl 1:90-3.PMID: 11369831 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Comparison of the effects of amlodipine and losartan on 24-hour ambulatory blood pressure in hypertensive patients.

    Ishimitsu T, Minami J, Yoshii M, Suzuki T, Inada H, Ohta S, Futoh Y, Ono H, Matsuoka H.

    Clin Exp Hypertens. 2002 Jan-Feb;24(1-2):41-50.PMID: 11848168 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients.

    Minami J, Ishimitsu T, Kawano Y, Matsuoka H.

    Clin Exp Pharmacol Physiol. 1998 Jul-Aug;25(7-8):572-6.PMID: 9673431 [PubMed - indexed for MEDLINE]Related articles

    10.

    Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics.

    Lozano JV, Llisterri JL, Aznar J, Redon J; Spanish Working Group.

    Nephrol Dial Transplant. 2001;16 Suppl 1:85-9.PMID: 11369830 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study]

    Goicolea I, Fernández González R, Piniés J, Garrido J, Martínez JM, Armenteros S, Moreno Carretero E.

    Nefrologia. 2002;22(2):170-8. Spanish. PMID: 12085418 [PubMed - indexed for MEDLINE]Related articles

    13.

    Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.

    Nielsen S, Schmitz A, Poulsen PL, Hansen KW, Mogensen CE.

    Diabetes Care. 1995 Nov;18(11):1434-41.PMID: 8722066 [PubMed - indexed for MEDLINE]Related articles

    14.

    Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

    Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F.

    Diabetes Care. 1998 Apr;21(4):597-603.PMID: 9571349 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy.

    Alli C, Lombardo M, Zanni D, Agrati AM, Cassani M, Granata S.

    Am J Hypertens. 1996 Nov;9(11):1068-76.PMID: 8931831 [PubMed - indexed for MEDLINE]Related articles

    17.

    Perindopril effects on ambulatory blood pressure: relation to sympathetic nervous activity in subjects with diabetic nephropathy.

    Yasuda G, Hasegawa K, Kuji T, Ogawa N, Shimura G, Umemura S, Tochikubo O.

    Am J Hypertens. 2004 Jan;17(1):14-20.PMID: 14700506 [PubMed - indexed for MEDLINE]Related articles

    18.

    Optimal dose of losartan for renoprotection in diabetic nephropathy.

    Andersen S, Rossing P, Juhl TR, Deinum J, Parving HH.

    Nephrol Dial Transplant. 2002 Aug;17(8):1413-8.PMID: 12147788 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Losartan titration versus diuretic combination in type 2 diabetic patients.

    de Pablos-Velasco PL, Pazos Toral F, Esmatjes JE, Fernandez-Vega F, Lopez de la Torre ML, Pozuelo A, Ruilope LM.

    J Hypertens. 2002 Apr;20(4):715-9.PMID: 11910308 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.

    Karas M, Lacourcière Y, LeBlanc AR, Nadeau R, Dubé B, Florescu M, Lamarre-Cliche M, Poirier L, Larochelle P, de Champlain J.

    J Hypertens. 2005 Jun;23(6):1251-60.PMID: 15894902 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data